English
norskBlar i forfatter "Norum, Jan"
Viser treff 1-20 av 36
-
Air ambulance flights in northern Norway 2002- 2008. Increased number of secondary fixed wing (FW) operations and more use of rotor wing (RW) transports
(Journal article; Tidsskriftartikkel; Peer reviewed, 2011)Air ambulance service in Norway has been upgraded during the last years. European regulations concerning pilots’ working time and new treatment guidelines/strategies have called for more resources. The objective was to describe and analyse the two supplementary air ambulance [fixed wing (FW) and rotor wing (RW)] alternatives’ activity during the study period (2002-2008). Furthermore we aimed to ... -
Air ambulance services in the Arctic 1999-2009 : a Norwegian study.
(Journal article; Tidsskriftartikkel; Peer reviewed, 2011)Air ambulance services in the Arctic have to deal with remote locations, long distances, rough weather conditions and seasonable darkness. Despite these challenges, the people living in the area expect a high quality of specialist health care. The objective of this study was to analyse the air ambulance operations performed in the Norwegian Arctic and study variations in diagnoses and flight patterns ... -
Brain Damage Treated with Non Proven Intensive Training 2003-2011: A Norwegian Cost Analysis
(Journal article; Tidsskriftartikkel, 2012)There has been an increased request for intensive training and rehabilitation of patients with brain damage in Norway. These programs are demanding with regard to personnel, travelling, time and economic resources. We aimed to indicate cost and gain to make these programs cost-effective. A retrospective study included all patients referred to the Northern Norway Regional Health Authority (NNRHA) ... -
Caesarean section rates and activity-based funding in Northern Norway: A model-based study using the World Health Organization's recommendation
(Journal article; Tidsskriftartikkel; Peer reviewed, 2018-07-16)<i>Objective</i>: Caesarean section (CS) rates vary significantly worldwide. ,e World Health Organization (WHO) has recommended a maximum CS rate of 15%. Norwegian hospitals are paid per CS (activity-based funding), employing the diagnosis-related group (DRG) system. We aimed to document how financial incentives can be affected by reduced CS rates, according to the WHO’s recommendation. <p> <p> ... -
Calculating the 30-day survival in acute myocardial infarction: should we use the treatment chain or the hospital catchment model?
(Journal article; Tidsskriftartikkel; Peer reviewed, 2017-01-12)<p><i>Introduction</i> Acute myocardial infarction (AMI) is a potentially deadly disease and significant efforts have been concentrated on improving hospital performance. A 30-day survival rate has become a key quality of care indicator. In Northern Norway, some patients undergoing AMI are directly transferred to the Regional Cardiac Intervention Center at the University Hospital of North Norway ... -
Comorbidity, Use of Common Medications, and Risk of Early Death in Patients with Localized or Locally Advanced Prostate Cancer
(Journal article; Tidsskriftartikkel; Peer reviewed, 2011-06-09)In this paper, we analyze predictive factors for early death from comorbidity (defined as death within 3 years from diagnosis and unrelated to prostate cancer) in patients with localized or locally advanced prostate cancer. Such information may guide individually tailored treatment or observation strategies, and help to avoid overtreatment. We retrospectively analyzed baseline parameters including ... -
Cost-effectiveness and quality of life in surgeon versus general practitioner-organised colon cancer surveillance: a randomised controlled trial
(Journal article; Tidsskriftartikkel; Peer reviewed, 2013-04-04)Objective: To assess whether colon cancer follow-up can be organised by general practitioners (GPs) without a decline in the patient's quality of life (QoL) and increase in cost or time to cancer diagnoses, compared to hospital follow-up. Design: Randomised controlled trial. Setting: Northern Norway Health Authority Trust, 4 trusts, 11 hospitals and 88 local communities. Participants: Patients ... -
Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
(Journal article; Tidsskriftartikkel; Peer reviewed, 2017-06-21)Background: <br> Identification of BRCA mutations in breast cancer (BC) patients influences treatment and survival and may be of importance for their relatives. Testing is often restricted to women fulfilling high-risk criteria. However, there is limited knowledge of the sensitivity of such a strategy, and of the clinical aspects of BC caused by BRCA mutations in less selected BC cohorts. The aim ... -
Have Changes in Systemic Treatment Improved Survival in Patients with Breast Cancer Metastatic to the Brain?
(Journal article; Tidsskriftartikkel; Peer reviewed, 2008-07-16)Newly developed systemic treatment regimens might lead to improved survival also in the subgroup of breast cancer patients that harbour brain metastases. In order to examine this hypothesis, a matched pairs analysis was performed that involved one group of patients, which were treated after these new drugs were introduced, and one group of patients, which were treated approximately 10 years earlier. ... -
Health consumption in Sami-speaking municipalities with regard to cancer and radiotherapy
(Journal article; Tidsskriftartikkel; Peer reviewed, 2012-03-18)Objectives. The objective of this study was to document that the Sami people, constituting an ethnic minority in northern Norway, experience an equally available specialist health care service as the one offered to Norwegians in general. We aimed to use cancer and radiotherapy treatment as the instrument to clarify the situation.<p> <p>Study design. A retrospective registry-based study.<p> <p>Methods. ... -
Health Economics and Radium-223 (Xofigo®) in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Case History and a Systematic Review of the Literature
(Journal article; Peer reviewed; Tidsskriftartikkel, 2015)OBJECTIVES: Prostate cancer (PC) is the most common cancer in Western countries. Recent advances in the treatment of metastatic castration resistant prostate cancer (mCRPC) have caused significant pressure on health care budgets. We aimed to exemplify this dilemma presenting an example, radium-223 (Xofigo®), and review the literature. METHODS: A 74-year-old man diagnosed with mCRPC was referred ... -
Helseøkonomisk evaluering av bevacizumab ved metastatisk kolorektalcancer
(Research report; Forskningsrapport, 2007)Vi har gjennomført en modellbasert analyse av kostnadseffektiviteten av bevacizumab som førstelinjebehandling av metastatisk kolorektalcancer (tykk- og endetarmskreft) i Norge. Vi har undersøkt effekten av å legge bevacizumab til standard kjemoterapi. Beregningene er forbundet med betydelig usikkerhet, og resultatene bør derfor tolkes med forsiktighet. -
Induced abortion on demand and birth rate in Sami-speaking municipalities and a control group in Finnmark, Norway
(Journal article; Tidsskriftartikkel; Peer reviewed, 2013)Objectives. The objective of this study was to analyze the birth and induced abortion on demand (IAD) rate among women in Sami-speaking communities and a control group in Finnmark County, Norway. Methods. The 6 northern municipalities included in the administration area of the Sami language law (study group) were matched with a control group of 9 municipalities. Population data (numbers, sex and ... -
Initiation of systemic therapy during the last 30 days of life in patients with metastatic castration-resistant prostate cancer
(Journal article; Tidsskriftartikkel; Peer reviewed, 2019)<b>Background/Aim</b>: Compared to intravenous taxane chemotherapy, newer orally-available and/or less toxic agents for metastatic castration-resistant prostate cancer (MCRPC) may be associated with higher likelihood of starting treatment in patients with adverse prognostic features and limited life expectancy. To test this hypothesis, we analyzed the rates of treatment initiation during the last ... -
Mammographic screening in Sami speaking municipalities and a control group. Are early outcome measures influenced by ethnicity?
(Journal article; Tidsskriftartikkel; Peer reviewed, 2012-04-16)Objectives. Female citizens of Sami (the indigenous people of Norway) municipalities in northern Norway have a low risk of breast cancer. The objective of this study was to describe the attendance rate and outcome of the Norwegian Breast Cancer Screening Program (NBCSP) in the Sami-speaking municipalities and a control group.<p> <p>Study design. A retrospective registry-based study.<p> <p>Methods. ... -
Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?
(Journal article; Tidsskriftartikkel; Peer reviewed, 2019-05-23)The goal of the Norwegian Ministry of Health and Care Services is to offer an equal health-care service with the same outcomes wherever people are living within the country. The aim of this study was to evaluate whether this was true for patients diagnosed with metastatic prostate cancer (mPC) and living in Nordland County, a region with a challenging geography and climate and having, several small ... -
Medical Treatment of Children and Youths with Attention-Deficit/Hyperactivity Disorder (ADHD): A Norwegian Prescription Registry Based Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Most Scandinavians Are Born During Summer Time and Less Norwegians Are Born the First Quarter of the Year: A Study Comparing Scandinavian Birth Patterns 2000-2012
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
A nutrition problem solved by a two-step endoscopic removal of a non-adjustable gastric band
(Journal article; Tidsskriftartikkel; Peer reviewed, 2018-11-01)Bariatric surgery is an effective approach for weight loss and short-term improvement in metabolic disorders. Stenosis is a common complication of gastric banding. Balloon dilatation or gastrotomy has been employed in this setting. Few studies have indicated endoscopic removal of the band a feasible procedure. We present a 60-year-old female who underwent gastric banding in 1985 and suffered from ... -
Ny medikamentell behandling av brystkreft - Adjuvant behandling med trastuzumab ved tidlig stadium av brystkreft
(Research report; Forskningsrapport, 2006)Denne rapporten er første del av et oppdrag fra Sosial- og helsedirektoratet og RHF - fagdirektørene med fokus på effekt og bivirkninger av virkestoffet trastuzumab ved adjuvant behandling av brystkreft. Trastuzumab er ofte omtalt ved produktnavnet Herceptin.
